XERS Xeris Biopharma Holdings, Inc.
Price Chart
Executive Summary
Director Marla Persky filed a Form 144 notice of intent to sell 15,500 shares of XERS common stock, with an estimated aggregate market value of $93,000. The shares were acquired via restricted stock units on June 3, 2026. This is a small, routine sale by a non-executive director — the dollar value is negligible relative to the company's $1.1B market cap and represents no material insider signal.
Actionable Insight
This is a de minimis proposed sale by a director. No actionable signal for traders — the filing is routine and carries no material information about company fundamentals or insider sentiment. Monitor for any larger insider sales ahead of next earnings.
Key Facts
- Filer: Director Marla Persky (non-executive board member)
- Shares to be sold: 15,500 shares of common stock
- Estimated value: $93,000 (based on filing date price of ~$6.00/share)
- Shares acquired via restricted stock units on June 3, 2026
- Sale intended to be executed through Morgan Stanley Smith Barney
- Market cap of XERS: ~$1.1B — sale represents ~0.008% of market cap
- Recent insider activity (30d): 1 prior sell totaling $101K
Financial Impact
Proposed sale of $93,000 in stock by a director — immaterial relative to $1.1B market cap
Risk Factors
- No material risk identified from this filing alone
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005565 |
| Document: 0001950047-26-005565-index.html | 0001950047-26-005565 |
| Document: 0001950047-26-005565.txt | 0001950047-26-005565 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
3d ago
|
Institutional Cluster
| $6.93 awaiting T+1 | awaiting T+1 | — | $6.79 (−2.02%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 5, 2026
9d ago
|
Insider Cluster
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 4, 2026
10d ago
|
144
| $6.17 awaiting T+1 | awaiting T+1 | — | $6.79 (+10.05%) |
|
Jun 3, 2026
11d ago
|
144
| $6.15 $6.18 | ▲ +0.49% | ▲ +3.06% | $6.79 (+10.41%) |
|
Feb 27, 2026
15w ago
|
8-K
| $6.12 $6.02 | ▼ −1.63% | ▼ −1.69% | $6.79 (+10.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access